Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
nicotinell lakrids lyfjatyggigúmmí 4 mg
haleon denmark aps - nicotinum resin-komplex - lyfjatyggigúmmí - 4 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
nicotinell lakrids lyfjatyggigúmmí 2 mg
haleon denmark aps - nicotinum resin-komplex - lyfjatyggigúmmí - 2 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
zyvoxid innrennslislyf, lausn 2 mg/ml
pfizer aps - linezolidum inn - innrennslislyf, lausn - 2 mg/ml
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
suliqua
sanofi winthrop industrie - insúlín glargine, lixisenatide - sykursýki, tegund 2 - lyf notuð við sykursýki - suliqua is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise in addition to metformin with or without sglt-2 inhibitors.
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
zyvoxid filmuhúðuð tafla 600 mg
pfizer aps - linezolidum inn - filmuhúðuð tafla - 600 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
nicotinell mint lyfjatyggigúmmí 4 mg
haleon denmark aps - nicotinum resin-komplex - lyfjatyggigúmmí - 4 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
nicotinell mint lyfjatyggigúmmí 2 mg
haleon denmark aps - nicotinum resin-komplex - lyfjatyggigúmmí - 2 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
afipran stungulyf, lausn 5 mg/ml
orifarm healthcare a/s - metoclopramidum hýdróklóríð - stungulyf, lausn - 5 mg/ml
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
afipran tafla 10 mg
orifarm healthcare a/s - metoclopramidum hýdróklóríð - tafla - 10 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
imodium filmuhúðuð tafla 2 mg
mcneil sweden ab - loperamidum hýdróklóríð - filmuhúðuð tafla - 2 mg